Introduction to Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop
If you are looking for information about Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop, you have come to the right place. CDER's Director of Division of Clinical Compliance Evaluation Ni A. Khin, M.D. defines good clinical practice (
Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop Comprehensive Overview
MHRA's Expert Cynthia F. Kleppinger from CDER's Office of Scientific Investigations describes what a Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality.
Phillip D. Kronstein from CDER's Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an ...
Summary & Highlights for Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop
- CDER's Deputy Center Director for Clinical Science Robert J. Temple, M.D., shares case studies and FDA
- CDER's Director of the Division of Generic Drug Bioequivalence Evaluation Seongeun (Julia) Cho discusses bioequivalence ...
- This webinar from NSF expert George Toscano covers the trends and priorities when assuring
- Stacey Bruzzese welcomes back Chris Wubbolt, Principal of QACV Consulting, to the show. Today, Stacey and Chris will be ...
- MHRA's Lead Senior
We hope this detailed breakdown of Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop was helpful.
